Target intelligence / Profile preview

Natural killer cell chemokine receptors (NK chemokine receptors)

Target
NK chemokine receptors
Molecular classification
G protein-coupled receptor, Receptor
01

Overview

Natural killer (NK) cell chemokine receptors are a group of G protein-coupled receptors (GPCRs) expressed on the surface of NK cells that mediate their migration toward chemokine gradients within the tumor microenvironment (TME). Key receptors include CXCR3, CX3CR1, CCR2, CCR5, and CXCR4, which respond to specific ligands like CXCL9, CXCL10, and CCL5 produced by tumor or stromal cells. In the context of oncology, these receptors are critical for the successful infiltration of NK cells into solid tumors, where they exert potent anti-tumor cytotoxic effects. Therapeutic strategies often focus on enhancing the expression of these receptors on NK cells (e.g., via CAR-NK engineering) or modulating the TME chemokine profile to improve the recruitment and retention of these effector cells. Conversely, some chemokine pathways are targeted for inhibition if they contribute to immune evasion or the recruitment of regulatory cell types that suppress NK cell activity.

Other names
NK cell-associated chemokine receptorsC-X-C motif chemokine receptorsC-C motif chemokine receptorsNK cell trafficking receptors
02

Mechanism of action

Agonism to enhance NK cell recruitment into the tumor microenvironment; Antagonism to prevent NK cell sequestration or to inhibit pro-tumorigenic signaling; Modulation of chemokine gradients to favor effector cell infiltration.

03

Biological functions

Cell migrationChemotaxisImmune responseSignal transductionLeukocyte recruitment
04

Disease associations

CancerInflammationAutoimmune diseaseInfection
05

Safety considerations

Off-target inflammatory responsesAutoimmunity due to systemic immune activationPotential for promoting metastasis if certain receptors (e.g., CXCR4) are broadly inhibitedCytokine release syndrome
06

Interacting drugs

Mogamulizumab

4 more in the full profile.

07

Biomarkers

CXCR3 expression levelCXCL9/CXCL10 serum levelsNK cell infiltration density (CD56+)CCL5 expression in tumor tissue

Beyond the preview

Go deeper on Natural killer cell chemokine receptors (NK chemokine receptors).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Natural killer cell chemokine receptors (NK chemokine receptors).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call